Product Images Ciprofloxacin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Ciprofloxacin NDC 13107-076 by Aurolife Pharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 250 MG (1000 TABLETS BOTTLE) - ciprofloxacin fig1

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 250 MG (1000 TABLETS BOTTLE) - ciprofloxacin fig1

Ciprofloxacin Tablets are a medication that contains 250mg of ciprofloxacin USP in each film coated tablet. The usual dosage and administration are indicated in the package insert. They should be stored at 20° to 25°C and can be kept at 15° to 30°C occasionally. It is recommended to refer to the USP Controlled Room Temperature. This product is available in batches and is valid until a stated expiration date. This medication is exclusively available through prescription and comes in a pack of 1000 tablets. Medication guide is to be provided separately. The manufacturer of this product is Aurobindo Pharma USA, Inc. and is manufactured by Aurolife Pharma, LLC in Dayton, NJ 08810.*

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 500 MG (1000 TABLETS BOTTLE) - ciprofloxacin fig2

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 500 MG (1000 TABLETS BOTTLE) - ciprofloxacin fig2

Ciprofloxacin Tablets, USP are a medication in tablet form containing 500mg of ciprofloxacin hydrochloride. The package insert contains information on the usual dosage and administration of the drug. They should be stored at a controlled room temperature between 20°C to 25°C and permitted excursions to 15°C to 30°C. The medicine is dispensed with a medication guide provided separately by a pharmacist. The tablets are produced by Aurolife Pharma and manufactured for Aurobindo Pharma USA, and have a batch and an expiry date mentioned as LM-079, and the revised date is April 2009.*

ciprofloxacin structure - ciprofloxacin str1

ciprofloxacin structure - ciprofloxacin str1

ciprofloxacin structure 2 - ciprofloxacin str2

ciprofloxacin structure 2 - ciprofloxacin str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.